SBRI Healthcare supports novel technologies that aim to revolutionise primary care and GP services
Academic Health Science Networks (AHSNs) are co-developing novel technologies for primary care as part of the SBRI Healthcare programme. Innovations that could revolutionise GP Services have been funded to address the challenges of an ageing population.
Recognising the current pressures in primary care and need to advance the future of general practice, 22 companies share in a £2.1 million investment to develop and commercialise novel technologies with the potential to revolutionise GP services. This competition was led by Eastern AHSN, South West AHSN and West of England AHSN.
Technologies were sought in three main challenge areas for general practice. Winning innovations include: a device that measures novel biomarkers in a patient’s breath to immediately distinguish a viral from a bacterial respiratory tract infection allowing the GP to prescribe antibiotics quickly and appropriately; and a technology that allows for automatic vital sign measurement – heart rate, respiratory rate, blood pressure and oxygen saturation – whilst booking in with the receptionist, optimising the patient’s visit and maximising time with the GP.
Dr Liz Mear, Chair of the AHSN Network, commented: “There are few areas of our daily lives that remain untouched by technological advancement. Through the SBRI Healthcare programme, the AHSN Network is working with industry partners to develop solutions that will help deliver high quality GP services to a growing and aging population, and ensure patients across the country benefit from new and innovative technologies.”
Professor Helen Stokes-Lampard, Chair of the Royal College of GPs, said: “General practice has always been a trail blazer for adopting new innovations in our daily practice. At a time when our profession is under intense resource and workforce pressures, it is important that we continue to encourage and support new ideas that can benefit the care we deliver to patients, and make life that little bit easier for healthcare professionals right across the NHS.”
The programme works with leading healthcare players to identify areas where technology can be applied to address healthcare challenges. The 22 successful projects have been selected for their potential value to the health service and on the improved outcomes delivered to patients. The companies will be supported and fully funded to demonstrate the technical feasibility of their proposed concept for a six-month development phase.
With awards of up to £100,000 each, the successful companies (and supporting AHSNs) are:
- Anglia Ruskin Enterprise (Eastern AHSN)
- Cambridge Respiratory Innovations (Eastern AHSN)
- Covolution (UCLPartners)
- Digital Algorithms (West of England AHSN)
- Healum (UCLPartners)
- Helicon Health (UCLPartners)
- MSKnote (Kent, Surrey & Sussex AHSN)
- MyDiabetesMyWay (Scotland)
- Orsus Medical (West of England AHSN)
- Ulsys (Yorkshire and Humber AHSN)
- uMotif (Health Innovation Network, South London)
Diagnostics and earlier triage
- Applied Nanodetectors (UCLPartners)
- Fraunhofer UK Research (Scotland)
- Manus Neurodynamica (Scotland)
- Medtechtomarket Consulting (Innovation Agency, North West Coast)
- Saccade Diagnostics (Scotland)
Workload and demand management
- Advanced Therapeutic Materials (West Midlands AHSN)
- Doc Abode (Yorkshire & Humber AHSN)
- iPLATO Healthcare (Imperial College Health Partners)
- nquiringminds (Wessex AHSN)
- xim (Wessex AHSN)
- Xytal Technology (South West AHSN)
To find out more about the programme, visit www.sbrihealthcare.co.uk